Sky Century Investment (SKYI) Non Operating Income (2024 - 2025)

Sky Century Investment (SKYI) reported Non Operating Income of -$81.0 for Q1 2025, up 84.21% quarter-over-quarter from -$513.0 in Q4 2024.

Sky Century Investment (SKYI) Non Operating Income (2024 - 2025) Analysis & Trends

Sky Century Investment (SKYI) has 2 years of Non Operating Income data on file, last reported at -$81.0 in Q1 2025.

Non Operating Income for Q1 2025 came in at -$81.0, changed N/A year-over-year; the trailing twelve-month figure through Nov 2025 was -$81.0 (up 84.21% YoY), and the FY2025 annual result was -$594.0, changed N/A from the prior year.
Non Operating Income improved to -$81.0 in Q1 2025 per SKYI's latest filing, from -$513.0 in the prior quarter.
Over five years, Non Operating Income peaked at $12000.0 in Q2 2024 and troughed at -$12000.0 in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non Op. Inc. (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	-216.00 Mn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	20.00 Mn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-7.50 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-504,111.66
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	53.40 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	-13.65 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	-23.23 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	5.71 Mn
10	Sky Century Investment	-	-	31,666.00	-

Download Data